NCT01371981 2025-11-26Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting1,645 enrolled 32 charts
NCT04797767 2025-10-15Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid NeoplasmsUniversity of WashingtonPhase 1/2 Recruiting62 enrolled